Bristol Myers Squibb · 3 hours ago
Director, Global Commercial Strategy Oncology - BioNTech/Solid Tumor
Princeton, NJ
Full-time
Onsite
Director/Executive
$198K/yr - $240K/yr
7+ years expBristol Myers Squibb is a company that transforms the lives of patients, and they are seeking a Director for Global Commercial Strategy in Oncology. This role will be responsible for driving strategic direction and commercial success of the BioNTech and solid tumor portfolio.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Lead the development and execution of global commercial strategies for BioNTech and solid tumor assets, in alignment with overall oncology portfolio objectives
Partner closely with Tumor Leads, Business Development, Medical, Market Access, and other stakeholders to drive integrated franchise plans and end-to-end accountability
Analyze market trends, competitive intelligence, and customer insights to inform strategic decisions and identify growth opportunities
Support launch readiness and lifecycle management for pipeline and in-market assets, including scenario planning and risk mitigation
Collaborate with Portfolio Strategy & Operations, Market Foresight, and Project Management teams to ensure operational excellence and cross-tumor alignment
Contribute to business development activities, including asset evaluation and partnership opportunities
Prepare and present business cases, strategic recommendations, and performance updates to senior leadership
Mentor and develop talent within the franchise, supporting succession planning and team capability building
Qualification
Required
Advanced degree in business, life sciences, or related field (MBA, PhD, PharmD preferred)
Minimum 7 years of experience in oncology commercial strategy, marketing, or related roles within the pharmaceutical/biotech industry
Proven ability to lead cross-functional teams and influence stakeholders in a matrixed global environment
Deep understanding of the oncology market landscape, including solid tumors and immuno-oncology
Strong analytical, strategic planning, and communication skills
Strategic agility and commercial acumen
Cross-functional collaboration and stakeholder management
Results orientation and accountability
Change leadership and adaptability
Talent development and team leadership
Preferred
Experience with asset launches, lifecycle management, and business development is preferred
Benefits
Medical, pharmacy, dental and vision care
Wellbeing support such as the BMS Living Life Better program and employee assistance programs (EAP)
Financial well-being resources and a 401(K)
Financial protection benefits such as short- and long-term disability, life insurance, supplemental health insurance, business travel protection and survivor support
Work-life programs include paid national holidays and optional holidays, Global Shutdown Days between Christmas and New Year's holiday, up to 120 hours of paid vacation, up to two (2) paid days to volunteer, sick time off, and summer hours flexibility
Parental, caregiver, bereavement, and military leave
Family care services such as adoption and surrogacy reimbursement, fertility/infertility benefits, support for traveling mothers, and child, elder and pet care resources
Other perks like tuition reimbursement and a recognition program
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (213)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
2025-12-30
BioWorld Financial Watch
2025-12-29
2025-12-25
Company data provided by crunchbase